Intermittent abdominal pressure ventilation: feasibility and efficacy in neuromuscular disease. A case report



he standard treatment for patients with neuromuscular respiratory failure is non-invasive ventilation (NIV) as non-invasive ventilation support-setting (NVS). NVS is administered through a nasal or face mask and/or mouthpiece with the potential to cause nasal ulcers, discomfort, and/or aesthetic issues, resulting in poor compliance. We reported the observation of a 45-year-old woman with limb-girdle muscular dystrophy (LGMD), secondary to Dysferlin deficiency, who was on NVS since 2017 for nocturnal hypoventilation. In 2018, despite nocturnal ventilation, due to weight gain and daytime hypoventilation, a nasal mask was introduced. We initiated daytime intermittent abdominal pressure ventilation (IAPV) to mitigate cosmetic problems, improving in pO2 and decreasing in pCO2 versus baseline (52>84 mmHg, 46>33 mmHg respectively) at 6 (85 mmHg, 42 mmHg) and 18 months (93 mmHg, 38 mmHg), respectively. IAPV was effective, safe, and well-tolerated in our patients who did not tolerate standard daytime NVS with the known interface.



PlumX Metrics


Download data is not yet available.


Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care 2006;51:896-911; discussion 911-2.

Fiorentino G, Annunziata A, Gaeta AM, et al. Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives. Degener Neurol Neuromuscul Dis 2018;8:55-61. DOI:

Bach JR, Alba AS. Intermittent abdominal pressure ventilator in a regimen of noninvasive ventilatory support. Chest 1991;99:630-6. DOI:

Cardus D, Vallbona C, Spencer WA. Effects of three kinds of artificial respirators on the pulmonary ventilation and arterial blood of patients with chronic respiratory insufficiency. Dis Chest 1966;50:297-306. DOI:

Windisch W, Dreher M, Geiseler J, et al. Guidelines for non-invasive and invasive home mechanical ventilation for treatment of chronic respiratory failure - Update 2017. Pneumologie 2017;71:722-95.

Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50: 1602426. DOI:

Yang GF, Alba A, Lee M, Khan A. Pneumobelt for sleep in the ventilator user: clinical experience. Arch Phys Med Rehabil 1989;70:707-11.

Seliger GM, Zackson H, Nichols L, et al. Neurological improvement following respiratory support in syringomyelia: case report. Paraplegia 1990;28:526-8. DOI:

Banfi PI, Volpato E, Bach JR. Efficacy of new intermittent abdominal pressure ventilator for post-ischemic cervical myelopathy ventilatory insufficiency. Multidiscip Respir Med 2019;14:4. DOI:

De Mattia E, Iatomasi M, Garabelli B, et al. Use of the intermittent abdominal pressure ventilation to guarantee speech in a tracheostomized amyotrophic lateral sclerosis patient. Rev Port Pneumol (2006) 2017; 23236-9.

Hill NS. Clinical applications of body ventilators. Chest 1986;90:897-905. DOI:

Balestroni G, Bertolotti G. [EuroQol-5D (EQ-5D): an instrument for measuring the quality of life].[Article in Italian]. Monaldi Arch Chest Dis 2012;78:155-9.

No authors listed. The world health organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998;46:1569-85. DOI:


Physiotherapy - Case Reports
Neuromuscular disease, daytime ventilation, non-invasive ventilation
  • Abstract views: 203

  • PDF: 66
How to Cite
Puricelli, Cristina, Eleonora Volpato, Salvatore Sciurello, Antonello Nicolini, and Paolo Banfi. 2021. “Intermittent Abdominal Pressure Ventilation: Feasibility and Efficacy in Neuromuscular Disease. A Case Report”. Monaldi Archives for Chest Disease, August.

Most read articles by the same author(s)